Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Rheumatol. 2006 May;33(5):1018-20. Epub 2006 Mar 1.

Neurological complications of infliximab.

Author information

  • 1Department of Medicine, University of Calgary, Calgary, Alberta T2N 4NI.

Abstract

The use of anti-tumor necrosis factor-a (TNF-a) therapies has led to improved outcomes in the treatment of rheumatoid arthritis (RA). However, the use of these new therapeutic agents requires careful monitoring for adverse effects. We describe 3 patients who developed neurological disease closely associated with the use of infliximab, a monoclonal antibody that binds to and inactivates TNF-a. All had evidence of polyneuropathy, demyelinating in one and axonal in 2. One patient had a central nervous system syndrome. Physicians should be aware of these potential adverse effects when treating patients with infliximab.

PMID:
16511935
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk